Evidence map›Paper›PMID 35414915›Full record

ArticleClinical case reports2022

Adolescents with chronic hepatitis C might be good candidates for direct-acting antiviral therapy.

Ken Sato, Yuichi Yamazaki, Yuki Kanayama, Daisuke Uehara, Hiroki Tojima, Takayoshi Suga, Satoru Kakizaki, Naondo Sohara, Norio Horiguchi, Toshio Uraoka

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Ken SatoDepartment of Gastroenterology and Hepatology Gunma University Graduate School of Medicine Gunma Japan.ORCID https://orcid.org/0000-0002-3202-7983
Yuichi YamazakiDepartment of Gastroenterology and Hepatology Gunma University Graduate School of Medicine Gunma Japan.ORCID https://orcid.org/0000-0002-8633-2983
Yuki KanayamaDepartment of Gastroenterology and Hepatology Gunma University Graduate School of Medicine Gunma Japan.ORCID https://orcid.org/0000-0002-8639-5212
Daisuke UeharaDepartment of Gastroenterology and Hepatology Gunma University Graduate School of Medicine Gunma Japan.ORCID https://orcid.org/0000-0003-1093-9751
Hiroki TojimaDepartment of Gastroenterology and Hepatology Gunma University Graduate School of Medicine Gunma Japan.ORCID https://orcid.org/0000-0002-1646-2344
Takayoshi SugaDepartment of Gastroenterology and Hepatology Gunma University Graduate School of Medicine Gunma Japan.ORCID https://orcid.org/0000-0001-8417-1461
Satoru KakizakiDepartment of Gastroenterology National Hospital Organization Takasaki General Medical Center Gunma Japan.ORCID https://orcid.org/0000-0003-0224-7093
Naondo SoharaSohara Clinic Gunma Japan.ORCID https://orcid.org/0000-0002-2106-501X
Norio HoriguchiDepartment of General Medicine Gunma University Graduate School of Medicine Gunma Japan.ORCID https://orcid.org/0000-0003-0560-5669
Toshio UraokaDepartment of Gastroenterology and Hepatology Gunma University Graduate School of Medicine Gunma Japan.ORCID https://orcid.org/0000-0002-4425-4331
Gunma University · JPNational Hospital Organization Takasaki Medical Center · JPSohar University · OM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three Japanese adolescents with chronic hepatitis C were treated by direct-acting antivirals (DAAs). No adverse events or laboratory abnormalities were observed during and after DAA therapy, and a sustained virological response was achieved in all cases. The emotional functioning of the patients and their mothers were improved after DAA therapy.

Indexed as

adolescentschronic hepatitis Cdirect‐acting antiviralsJapanesespecial population

Identifiers

PMID35414915
PMCPMC8980949
OpenAlexW4223577616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.